Antiretroviral therapy and dyslipidaemia: unlocking the code.
Mallon
Patrick W G
PW
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, St. Vincent's Medical Centre, Sydney, Australia. p.mallon@cfi .unsw.edu.au
D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C / Q000235:genetics / Q000502:physiology; D050171:Dyslipidemias / Q000139:chemically induced* / Q000503:physiopathology; D005006:Ethnicity; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D044469:Racial Groups; D014280:Triglycerides / Q000378:metabolism
D044966:Anti-Retroviral Agents; D053305:Apolipoprotein C-III; D001056:Apolipoproteins C; D014280:Triglycerides